Resistance rate to antibiotics of Helicobacter pylori isolates in eastern Taiwan

Journal of Gastroenterology and Hepatology (Australia)

Volumn 22, Issue 5, 2007, Pages 720-723

  Hu, Chi Tan ^a   Wu, Chao Chuan ^b   Lin, Chih Yung ^a   Cheng, Chuan Chu ^a   Su, Siou Cing ^a   Tseng, Yi Hsiung ^c   Lin, Nien Tsung ^a  

^a TZU CHI UNIVERSITY   (Taiwan)

^b BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^c CENTRAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

Antibiotic resistance; Epsilometer test; Helicobacter pylori

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CLARITHROMYCIN; METRONIDAZOLE; TETRACYCLINE;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIUM ISOLATION; CONTROLLED STUDY; DIAGNOSTIC TEST; FEMALE; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SEX DIFFERENCE; TAIWAN;

EID: 34247231984     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2006.04743.x     Document Type: Article

References (24)

1. Everhart JE. Recent developments in the epidemiology of Helicobacter pylori. Gastroenterol. Clin. North. Am. 2000; 29: 559-78.
2. Lin JT, Wang JT, Wu MS et al. Seroprevalence study of Helicobacter pylori infection in patients with gastroduodenal diseases. J. Formos. Med. Assoc. 1994; 93: 122-7.
3. Kuipers EJ. Helicobacter pylori and the risk and management of associated diseases: gastritis, ulcer disease, atrophic gastritis and gastric cancer. Aliment. Pharmacol. Ther. 1997; 11 (Suppl. 1): 71-88.
4. Graham DY, de Boer WA, Tytgat GN. Choosing the best anti-Helicobacter pylori therapy: effect of antimicrobial resistance. Am. J. Gastroenterol. 1996; 91: 1072-6.
5. Al-Qurashi AR, El-Morsy F, Al-Quorain AA. Evolution of metronidazole and tetracycline susceptibility pattern in Helicobacter pylori at a hospital in Saudi Arabia. Int. J. Antimicrob. Agents 2001; 17: 233-6.
6. Boyanova L, Mentis A, Gubina M et al. The status of antimicrobial resistance of Helicobacter pylori in eastern Europe. Clin. Microbiol. Infec. 2002; 8: 388-96.
7. Cameron EA, Powell KU, Baldwin L et al. Helicobacter pylori: antibiotic resistance and eradication rates in Suffolk, UK, 1991-2001. J. Med. Microbiol. 2004; 53: 535-8.
8. Debets-Ossenkopp YJ, Herscheid AJ, Pot RG et al. Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxycillin, tetracycline and trovafloxacin in The Netherlands. J. Antimicrob. Chemother. 1999; 43: 511-15.
9. Kim JJ, Reddy R, Lee M et al. Analysis of metronidazole, clarithromycin and tetracycline resistance of Helicobacter pylori isolates from Korea. J. Antimicrob. Chemother. 2001; 47: 459-61.
10. Nahar S, Mukhopadhyay AK, Khan R et al. Antimicrobial susceptibility of Helicobacter pylori strains isolated in Bangladesh. J. Clin. Microbiol. 2004; 42: 4856-8.
11. Megraud F. Antibiotic resistance in Helicobacter pylori infection. Br. Med. Bull. 1998; 54: 207-16.
12. Thyagarajan SP, Ray P, Das BK et al. Geographical difference in antimicrobial resistance pattern of Helicobacter pylori clinical isolates from Indian patients: Multicentric study. J. Gastroenterol. Hepatol. 2003; 18: 1373-8.
13. Wang WH, Wong BC, Mukhopadhyay AK et al. High prevalence of Helicobacter pylori infection with dual resistance to metronidazole and clarithromycin in Hong Kong. Aliment. Pharmacol. Ther. 2000; 14: 901-10.
14. Wu H, Shi XD, Wang HT, Liu JX. Resistance of Helicobacter pylori to metronidazole, tetracycline and amoxycillin. J. Antimicrob. Chemother. 2000; 46: 121-3.
15. Wu CC, Chou PY, Hu CT et al. Clinical relevance of the vacA, iceA, cagA, and flaA genes of Helicobacter pylori strains isolated in Eastern Taiwan. J. Clin. Microbiol. 2005; 43: 2913-15.
16. Glupczynski Y, Labbe M, Hansen W, Crokaert F, Yourassowsky E. Evaluation of the E test for quantitative antimicrobial susceptibility testing of Helicobacter pylori. J. Clin. Microbiol. 1991; 29: 2072-5.
17. van Zwet AA, Vandenbroucke-Grauls CM, Thijs JC et al. Stable amoxicillin resistance in Helicobacter pylori. Lancet 1998; 352: 1595.
18. Sherif M, Mohran Z, Fathy H et al. Universal high-level primary metronidazole resistance in Helicobacter pylori isolated from children in Egypt. J. Clin. Microbiol. 2004; 42: 4832-4.
19. O'Callaghan CH, Morris A, Kirby SM, Shingler AH. Novel method for detection of β-lactamases by using a chromogenic cephalosporin substrate. Antimicrob. Agents Chemother. 1972; 1: 283-8.
20. Huang AH, Sheu BS, Yang HB et al. Impact of Helicobacter pylori antimicrobial resistance on the outcome of 1-week lansoprazole-based triple therapy. J. Formos. Med. Assoc. 2000; 99: 704-9.
21. Kato M, Yamaoka Y, Kim JJ et al. Regional differences in metronidazole resistance and increasing clarithromycin resistance among Helicobacter pylori isolates from Japan. Antimicrob. Agents Chemother. 2000; 44: 2214-16.
22. Chihu L, Ayala G, Mohar A et al. Antimicrobial resistance and characterization of Helicobacter pylori strains isolated from Mexican adults with clinical outcome. J. Chemother. 2005; 17: 270-6.
23. Dore MP, Piana A, Carta M et al. Amoxycillin resistance is one reason for failure of amoxycillin-omeprazole treatment of Helicobacter pylori infection. Aliment. Pharmacol. Ther. 1998; 12: 635-9.
24. Gerrits MM, Schuijffel D, van Zwet AA et al. Alterations in penicillin-binding protein 1A confer resistance to β-lactam antibiotics in Helicobacter pylori. Antimicrob. Agents Chemother. 2002; 46: 2229-33.